The Board of Shenzhen Salubris Pharmaceuticals Co., Ltd. (SZSE:002294) announced the spin-off of Medical Instrument Unit on March 28, 2023. Shenzhen Salubris Pharmaceuticals plans to list Medical Instrument Unit on Shanghai Star Market.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
31.21 CNY | -1.05% | -2.22% | -4.44% |
Apr. 23 | Salubris Pharmaceuticals' Q1 Profit Falls 5% Despite 23% Rise in Operating Income | MT |
Apr. 23 | Salubris Pharmaceuticals to Raise Capital of US Unit by $35 Million | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.44% | 4.71B | |
+19.62% | 43.27B | |
+25.09% | 22.92B | |
+20.29% | 15.43B | |
+7.48% | 12.95B | |
+42.51% | 11.83B | |
-8.51% | 6.91B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.13% | 5.55B |
- Stock Market
- Equities
- 002294 Stock
- News Shenzhen Salubris Pharmaceuticals Co., Ltd.
- Shenzhen Salubris Pharmaceuticals Co., Ltd. agreed to Spin-Off Medical Instrument Unit of Shenzhen Salubris Pharmaceuticals Co Ltd.